Healthcare · NIFTY 500

Laurus Labs Limited

NSELAURUSLABS BSE540222 ISININE947Q01028 SeriesEQ Listed on NSE · BSE

₹2,400.00 -29.00 (-1.19%) Updated 12 Nov, 8:49 pm IST

Open chart Back to screener

Price, daily close+138.01% in a year

Today

Open: ₹2,427.00
Prev close: ₹2,429.00
Day high: ₹2,434.20
Day low: ₹2,380.00
Volume: 17.66 L
Value traded: ₹424.86 Cr
Upper circuit: ₹2,466.80
Lower circuit: ₹2,323.20
52W high: ₹2,441.90
52W low: ₹917.95
1 month: +17.12%
6 months: +84.72%

52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.

Market cap₹129,672 Cr

P/E (TTM)96.85

P/B21.40

Book value / share₹112.17

EPS (TTM)₹24.78

ROE22.1%

Dividend yield0.09%

Dividend (12m)₹2.20 / share

Net margin (TTM)17.1%

Operating margin34.0%

Debt / equity0.41

Current ratio1.31

EV / EBITDA55.50

Sales growth (YoY qtr)+33.44%

Profit growth (YoY qtr)+126.43%

Sales CAGR 3Y+4.09%

Profit CAGR 3Y+4.00%

Shares54.03 Cr

Quarterly results

Results for each quarter

Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.

Revenue and net profit

1,19523.1

Dec 23

1,44075.6

Mar 24

1,19512.5

Jun 24

1,22419.8

Sep 24

1,41592.3

Dec 24

1,720234

Mar 25

1,570163

Jun 25

1,653195

Sep 25

1,778252

Dec 25

1,812279

Mar 26

2,026368

Jun 26

2,206441

Sep 26

Revenue · QoQ (vs last quarter)

—+20%-17%+2.4%+16%+22%-8.8%+5.3%+7.5%+1.9%+12%+8.9%

Revenue · YoY (vs a year ago)

————+18%+19%+31%+35%+26%+5.3%+29%+33%

Net profit · QoQ (vs last quarter)

—+227%-83%+59%+365%+153%-30%+20%+29%+11%+32%+20%

Net profit · YoY (vs a year ago)

————+299%+209%+1,203%+883%+173%+19%+125%+126%

RevenueNet profitLine = trend

0.43

Dec 23

1.40

Mar 24

0.23

Jun 24

0.37

Sep 24

1.71

Dec 24

4.33

Mar 25

3.02

Jun 25

3.61

Sep 25

4.65

Dec 25

5.17

Mar 26

6.80

Jun 26

8.16

Sep 26

EPS (₹) · YoY (vs a year ago)

————+298%+209%+1,213%+876%+172%+19%+125%+126%

EPS (₹)Line = trend

₹ Cr	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25	Dec 25	Mar 26	Jun 26	Sep 26
Revenue	1,195	1,440	1,195	1,224	1,415	1,720	1,570	1,653	1,778	1,812	2,026	2,206
Other income	2.4	18.5	2.5	4.6	9.4	58.6	10.4	27.0	5.8	11.8	9.2	13.0
Total income	1,197	1,458	1,197	1,228	1,424	1,779	1,580	1,680	1,784	1,823	2,035	2,219
Raw material	634	591	572	577	653	626	599	677	725	793	786	901
Purchases	17.5	40.8	22.7	25.6	34.8	22.3	38.5	30.7	55.1	48.2	35.1	45.0
Employee cost	155	161	174	179	189	178	215	216	229	236	259	266
Other expenses	313	315	313	318	331	339	335	371	374	364	373	374
Total expenses	1,163	1,351	1,179	1,205	1,294	1,467	1,356	1,411	1,457	1,462	1,554	1,628
Operating profit	181	241	171	178	285	421	382	403	480	512	638	750
OPM %	15.2%	16.8%	14.3%	14.6%	20.2%	24.4%	24.3%	24.4%	27.0%	28.3%	31.5%	34.0%
Finance cost	50.8	50.5	49.2	52.6	57.8	56.4	51.5	40.0	38.8	40.4	42.2	44.1
Depreciation	98.4	102	106	108	106	110	117	120	121	122	124	127
Profit before tax	34.6	107	18.5	22.8	131	312	224	270	327	361	481	592
Tax	9.5	32.0	6.3	5.1	40.1	78.5	63.1	76.0	73.5	79.5	119	155
Net profit	23.3	75.0	12.7	20.0	92.9	233	162	194	252	282	362	436
Profit to shareholders	23.1	75.6	12.5	19.8	92.3	234	163	195	252	279	368	441
EPS (₹)	0.43	1.40	0.23	0.37	1.71	4.33	3.02	3.61	4.65	5.17	6.80	8.16

Profit & loss

Results for each year

8 financial years (April to March), consolidated, ₹ crore.

Sales, operating profit and net profit

2,2923560.0

FY19

2,8325650.0

FY20

4,8141,5510.0

FY21

4,9361,422828

FY22

6,0411,592790

FY23

5,041778161

FY24

5,5541,055358

FY25

6,8131,778889

FY26

Revenue · YoY (vs a year ago)

—+24%+70%+2.5%+22%-17%+10%+23%

Net profit · YoY (vs a year ago)

————-4.5%-80%+123%+148%

RevenueOperating profitNet profitLine = trend

₹ Cr	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	2,292	2,832	4,814	4,936	6,041	5,041	5,554	6,813
Other income	16.2	5.9	23.7	15.3	6.0	26.3	75.1	55.0
Total expenses	2,188	2,544	3,536	3,867	4,938	4,831	5,145	5,686
Employee cost	289	345	434	502	581	640	720	895
Operating profit	356	565	1,551	1,422	1,592	778	1,055	1,778
OPM %	15.5%	19.9%	32.2%	28.8%	26.4%	15.4%	19.0%	26.1%
Finance cost	88.2	89.6	68.2	102	165	183	216	171
Depreciation	164	187	205	251	324	385	430	480
Profit before tax	120	294	1,301	1,084	1,109	236	484	1,182
Tax	26.0	38.3	317	251	312	68.2	130	292
Tax rate %	21.7%	13.1%	24.4%	23.2%	28.2%	28.8%	26.8%	24.7%
Net profit	93.8	255	984	832	793	162	358	890
Profit to shareholders	0.0	0.0	0.0	828	790	161	358	889
Net margin %	0.0%	0.0%	0.0%	16.8%	13.1%	3.2%	6.5%	13.0%
EPS (₹)	8.80	23.93	18.28	15.35	14.64	2.97	6.64	16.45

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

4,0381,97245.7

Mar 23

4,1112,507139

Mar 24

4,4732,69399.5

Mar 25

5,3002,397113

Mar 26

6,0612,49024.5

Sep 26

Shareholders' equity · YoY (vs a year ago)

—+1.8%+8.8%+19%—

Shareholders' equityBorrowingsCashLine = trend

₹ Cr	Mar 23	Mar 24	Mar 25	Mar 26	Sep 26
Shareholders' equity	4,038	4,111	4,473	5,300	6,061
Long-term borrowings	761	798	646	611	553
Short-term borrowings	1,211	1,709	2,048	1,786	1,937
Total borrowings	1,972	2,507	2,693	2,397	2,490
Current liabilities	2,432	3,112	3,540	3,635	3,954
Fixed assets (PPE)	3,016	3,446	3,668	3,873	3,847
Inventories	1,685	1,845	1,937	2,342	2,659
Trade receivables	1,580	1,663	2,007	2,155	2,242
Cash & equivalents	45.7	139	99.5	113	24.5
Current assets	3,462	3,835	4,332	4,829	5,184
Total assets	7,660	8,387	9,336	10,511	11,514
Debt / equity	0.49	0.61	0.60	0.45	0.41

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

911-91430.3

FY22

994-996-26.6

FY23

666-822250

FY24

602-68239.3

FY25

1,624-1,089-525

FY26

Operations · YoY (vs a year ago)

—+9.1%-33%-9.6%+170%

OperationsInvestingFinancingLine = trend

₹ Cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	911	994	666	602	1,624
Cash from investing	-914	-996	-822	-682	-1,089
Cash from financing	30.3	-26.6	250	39.3	-525
Spent on fixed assets	-877	-990	-678	-641	-1,070
Free cash flow	34.3	3.7	-12.6	-39.4	554
Net cash flow	27.0	-28.8	93.1	-40.8	10.1

Shareholding

Who holds the shares

Promoter and public holding at each quarter end, as filed with NSE.

Holding over time

27.2%Dec 23

27.2%Mar 24

27.2%Jun 24

27.2%Sep 24

27.6%Dec 24

27.6%Mar 25

27.6%Jun 25

27.6%Sep 25

27.5%Dec 25

27.5%Mar 26

27.5%Jun 26

27.5%Sep 26

Promoter & groupPublic

Latest (30 Sep 2026)

27.5%promoter

Promoter & group: 27.47%
Public (FIIs, mutual funds, retail…): 72.53%
Promoter change, last quarter: 0.00 pts

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

Interim Dividend - Re 1 Per ShareEx 06-Nov-2026
Interim Dividend - Rs 1.20 Per ShareEx 08-May-2026
Interim Dividend - Re 0.80 Per ShEx 31-Oct-2025
Interim Dividend - Rs 0.80 Per ShareEx 09-May-2025
Interim Dividend - Rs 0.40 Per ShareEx 06-Nov-2024
Annual General MeetingEx 04-Jul-2024
Interim Dividend - Re 0.40 Per ShareEx 08-May-2024
Interim Dividend - Re 0.40 Per ShareEx 02-Nov-2023

Board meetings

the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Dividend.29-Oct-2026
the financial results for the period ended September 30, 2026 and dividend29-Oct-2026
LAURUS LABS LIMITED has informed the Exchange about Board Meeting to be held on 24-Jul-2026 to inter-alia consider and approve the Unaudited Financia…24-Jul-2026
the financial results for the period ended Jun 30, 202624-Jul-2026
the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.30-Apr-2026

Filings with NSE

Analysts/Institutional Investor Meet/Con. Call Updates10 Nov
Copy of Newspaper Publication6 Nov
Analysts/Institutional Investor Meet/Con. Call Updates3 Nov
Copy of Newspaper Publication30 Oct
Analysts/Institutional Investor Meet/Con. Call Updates29 Oct
Press Release29 Oct
Investor Presentation29 Oct

Latest news

LAURUSLABS Outlook for the WeekEquitypandit · 8 Nov, 1:30 pm Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upsideThe Economic Times · 16 Oct, 12:30 pm Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · 9 Nov, 12:23 pm Laurus Labs Shares Rise 5% After Q2 FY27 Net Profit Jumps 126%India Infoline · 30 Oct, 12:30 pm Laurus Labs shares fall 2.03% in Friday's tradeMoneycontrol.com · 14 Aug, 12:30 pm Laurus Labs (NSEI:LAURUSLABS) Stock Fair Value Rises After Analysts Lift Growth ExpectationsYahoo Finance · 15 Aug, 12:30 pm Laurus Labs Share Price Today and Sector Valuation ViewUnivest · 21 Oct, 12:30 pm Top 2 stocks to buy or sell for short-term: Laurus Labs, Canara Bank by Chandan Taparia - Check stop-loss, targetsLivemint · 2 Oct, 12:30 pm

About

About Laurus Labs Limited

Laurus Labs Limited is listed on the NSE under the symbol LAURUSLABS and belongs to the Healthcare sector.

Company details

Company name: Laurus Labs Limited
NSE symbol: LAURUSLABS
BSE scrip code: 540222
ISIN: INE947Q01028
Listed on: NSE, BSE
Series: EQ (normal equity)
Listed on NSE since: 19 Dec 2016
Face value: ₹2 per share
Market lot: 1 share
Shares issued: 54.03 crore
Index: NIFTY 500
Sector (NSE): Healthcare
Industry: Pharmaceuticals: Major
Managing director / CEO: Satyanarayana Chava
Chair: Ravindranath Kancherla
Headquarters: Hyderabad, Telangana, India
Registered address: Plot No. 103, Road No.1, Jubilee Hills, Hyderabad - 500033, Telangana, India
Founded: 2005
Employees: 13,832
Financial year: April to March
Results basis: Consolidated
Website: lauruslabs.com

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.

India, Wall Street, crypto and commodities, live.

Every product, one clear workflow.

Built from data, on the record.

A clearer view of the markets.

Calculators and tools that show the maths.

Read the numbers, not the noise.

Laurus Labs Limited

Today

Ratios

Quarterly results

Revenue and net profit

Profit & loss

Sales, operating profit and net profit

Balance sheet

Equity, debt and assets

Cash flow

Operating, investing and financing cash

Shareholding

Holding over time

Latest (30 Sep 2026)

Dividends & news

Dividends & corporate actions

Board meetings

Filings with NSE

Latest news

About

Company details

Peers